Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China · Delayed Price · Currency is CNY 24.38
-0.41 (-1.65%)
Apr 17, 2026, 4:00 PM EDT
SHA:688739 Market Cap
SHA:688739 has a market cap or net worth of 10.02 billion as of April 21, 2026. Its market cap has decreased by -9.42% in one year.
Market Cap
10.02B
Enterprise Value
4.96B
Revenue
1.39B
Ranking
n/a
PE Ratio
73.85
Stock Price
24.38
Market Cap Chart
Since October 28, 2021, SHA:688739's market cap has decreased from 33.32B to 10.02B, a decrease of -69.92%. That is a compound annual growth rate of -23.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 10.02B | -5.40% |
| Dec 31, 2025 | 10.59B | -0.17% |
| Dec 31, 2024 | 10.61B | -21.62% |
| Dec 29, 2023 | 13.54B | 6.87% |
| Dec 30, 2022 | 12.67B | -60.04% |
| Dec 31, 2021 | 31.70B | -4.84% |
| Oct 28, 2021 | 33.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chongqing Genrix Biopharmaceutical | 11.41B |
| Aurisco Pharmaceutical | 11.19B |
| Beijing Hotgen Biotech | 10.92B |
| HitGen | 10.75B |
| Jiangxi Fushine Pharmaceutical | 10.15B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.67B |
| Bio-Thera Solutions | 9.54B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 9.50B |